Recent insights into the biological functions of liver fatty acid binding protein 1

Journal of Lipid Research

Volumn 56, Issue 12, 2015, Pages 2238-2247

  Wang, GuQi ^a,b,c   Bonkovsky, Herbert L ^b,c,d   De Lemos, Andrew ^c,d   Burczynski, Frank J ^e  

^a JIANGXI NORMAL UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^c LEVINE CANCER INSTITUTE   (United States)

^d WAKE FOREST BAPTIST HEALTH   (United States)

^e UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Fatty liver; Heme; Infection; Inflammation; Liver regeneration; Metalloporphyrins; Nonalcoholic fatty liver disease; Oxidative stress; Steatosis

Indexed keywords

FATTY ACID BINDING PROTEIN; LIVER FATTY ACID BINDING PROTEIN 1; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; CELL PROTECTION; FATTY ACID TRANSPORT; GENE INACTIVATION; GENETIC VARIABILITY; HUMAN; LIPID METABOLISM; LIVER REGENERATION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; LIVER; METABOLISM; PHYSIOLOGY;

ANIMALS; FATTY ACID-BINDING PROTEINS; HUMANS; LIPID METABOLISM; LIVER; OXIDATIVE STRESS;

EID: 84948980463     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R056705     Document Type: Review

References (133)

1. Bordewick, U., M. Heese, T. Borchers, H. Robenek, and F. Spener . 1989 . Compartmentation of hepatic fatty-acid-binding protein in liver cells and its effect on microsomal phosphatidic acid biosynthesis. Biol. Chem. Hoppe Seyler . 370 : 229 - 238 .
2. Fahimi, H. D., A. Voelkl, S. H. Vincent, and U. Muller-Eberhard . 1990 . Localization of the heme-binding protein in the cytoplasm and of a heme-binding protein-like immunoreactive protein in the nucleus of rat liver parenchymal cells: immunocytochemicalevidence of the subcellular distribution corroborated by radioimmunoassay and immunoblotting. Hepatology . 11 : 859 - 865 .
3. Börchers, T., C. Unterberg, H. Rüdel, H. Robenek, and F. Spener . 1989 . Subcellular distribution of cardiac fatty acid-binding protein in bovine heart muscle and quantitation with an enzymelinked immunosorbent assay. Biochim. Biophys. Acta . 1002 : 54 - 61.
4. Ho, S. Y., and J. Storch . 2001 . Common mechanisms of monoacylglycerol and fatty acid uptake by human intestinal Caco-2 cells. Am. J. Physiol. Cell Physiol. 281 : C1106 - C1117 .
5. Pelsers, M. M., Z. Namiot, W. Kisielewski, A. Namiot, M. Januszkiewicz, W. T. Hermens, and J. F. Glatz . 2003 . Intestinaltype and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin. Biochem. 36 : 529 - 535 .
6. Uhlén, M., L. Fagerberg, B. M. Hallström, C. Lindskog, P. Oksvold, A. Mardinoglu, Å. Sivertsson, C. Kampf, E. Sjöstedt, A. Asplund, et al . 2015 . Proteomics. Tissue-based map of the human proteome. Science . 347 : 1260419.
7. Matsui, K., A. Kamijo-Ikemorif, T. Sugaya, T. Yasuda, and K. Kimura . 2011 . Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity. Am. J. Pathol. 178 : 1021 - 1032 .
8. Osaki, K., Y. Suzuki, T. Sugaya, C. Tanifuji, A. Nishiyama, S. Horikoshi, and Y. Tomino . 2013 . Amelioration of angiotensin IIinduced salt-sensitive hypertension by liver-type fatty acid-binding protein in proximal tubules. Hypertension . 62 : 712 - 718 .
9. Vergani, L., M. Fanin, A. Martinuzzi, A. Galassi, A. Appi, R. Carrozzo, M. Rosa, and C. Angelini . 1990 . Liver fatty acid-binding protein in two cases of human lipid storage. Mol. Cell. Biochem. 98 : 225 - 230.
10. Thompson, J., N. Winter, D. Terwey, J. Bratt, and L. Banaszak . 1997 . The crystal structure of the liver fatty acid-binding protein. A complex with two bound oleates. J. Biol. Chem. 272 : 7140 - 7150 .
11. Thompson, J., A. Reese-Wagoner, and L. Banaszak . 1999 . Liver fatty acid binding protein: species variation and the accommodation of different ligands. Biochim. Biophys. Acta . 1441 : 117 - 130 .
12. Kaczocha, M., M. J. Rebecchi, B. P. Ralph, Y. H. Teng, W. T. Berger, W. Galbavy, M. W. Elmes, S. T. Glaser, L. Wang, R. C. Rizzo, et al . 2014 . Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. PLoS One . 9 : E94200 .
13. Kaczocha, M., S. T. Glaser, and D. G. Deutsch . 2009 . Identifi cation of intracellular carriers for the endocannabinoid anandamide. Proc. Natl. Acad. Sci. USA . 106 : 6375 - 6380 .
14. Lagakos, W. S., X. Guan, S. Y. Ho, L. R. Sawicki, B. Corsico, S. Kodukula, K. Murota, R. E. Stark, and J. Storch . 2013 . Liver fatty acid-binding protein binds monoacylglycerol in vitro and in mouse liver cytosol. J. Biol. Chem. 288 : 19805 - 19815 .
15. Coe, N. R., and D. A. Bernlohr . 1998 . Physiological properties and functions of intracellular fatty acid-binding proteins. Biochim. Biophys. Acta . 1391 : 287 - 306.
16. Bass, N. M. 1988 . The cellular fatty acid binding proteins: Aspects of structure, regulation, and function. Int. Rev. Cytol. 111 : 143 - 184 .
17. Wolfrum, C., T. Borchers, J. C. Sacchettini, and F. Spener . 2000 . Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry . 39 : 1469 - 1474 .
18. Sorof, S., and R. P. Custer . 1987 . Elevated expression and cell cycle deregulation of a mitosis-associated target polypeptide of a carcinogen in hyperplastic and malignant rat hepatocytes. Cancer Res. 47 : 210 - 220 .
19. Custer, R. P., and S. Sorof . 1985 . Mitosis in hepatocytes is generally associated with elevated levels of the target polypeptide of a liver carcinogen. Differentiation . 30 : 176 - 181 .
20. Wang, G., Q. M. Chen, G. Y. Minuk, Y. Gong, and F. J. Burczynski . 2004 . Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats. Mol. Cell. Biochem. 262 : 41 - 49 .
21. Gajda, A. M., Y. X. Zhou, L. B. Agellon, S. K. Fried, S. Kodukula, W. Fortson, K. Patel, and J. Storch . 2013 . Direct comparison of mice null for liver or intestinal fatty acid-binding proteins reveals highly divergent phenotypic responses to high fat feeding. J. Biol. Chem. 288 : 30330 - 30344 .
22. Jefferson, J. R., D. M. Powell, Z. Rymaszewski, J. Kukowska-Latallo, J. B. Lowe, and F. Schroeder . 1990 . Altered membrane structure in transfected mouse L-cell fi broblasts expressing rat liver fatty acid-binding protein. J. Biol. Chem. 265 : 11062 - 11068 .
23. Lawrence, J. W., D. J. Kroll, and P. I. Eacho . 2000 . Liganddependent interaction of hepatic fatty acid-binding protein with the nucleus. J. Lipid Res. 41 : 1390 - 1401 .
24. Huang, H., O. Starodub, A. McIntosh, B. P. Atshaves, G. Woldegiorgis, A. B. Kier, and F. Schroeder . 2004 . Liver fatty acidbinding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells. Biochemistry . 43 : 2484 - 2500 .
25. Wolfrum, C., C. M. Borrmann, T. Borchers, and F. Spener . 2001 . Fatty acids and hypolipidemic drugs regulate peroxisome proliferator- Activated receptors alpha - And gamma-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus. Proc. Natl. Acad. Sci. USA . 98 : 2323 - 2328 .
26. Landrier, J. F., C. Thomas, J. Grober, H. Duez, F. Percevault, M. Souidi, C. Linard, B. Staels, and P. Besnard . 2004 . Statin induction of liver fatty acid-binding protein (L-FABP) gene expression is peroxisome proliferator-activated receptor-alpha-dependent. J. Biol. Chem. 279 : 45512 - 45518 .
27. Nakagawa, S., Y. Kawashima, A. Hirose, and H. Kozuka . 1994 . Regulation of hepatic level of fatty-acid-binding protein by hormones and clofi bric acid in the rat. Biochem. J. 297 : 581 - 584 .
28. Kawashima, Y., S. Nakagawa, Y. Tachibana, and H. Kozuka . 1983 . Effects of peroxisome proliferators on fatty acid-binding protein in rat liver. Biochim. Biophys. Acta . 754 : 21 - 27 .
29. Ockner, R. K., D. A. Burnett, N. Lysenko, and J. A. Manning . 1979 . Sex differences in long chain fatty acid utilization and fatty acid binding protein concentration in rat liver. J. Clin. Invest. 64 : 172 - 181 .
30. Besnard, P., L. Foucaud, A. Mallordy, C. Berges, R. M. Kaikaus, A. Bernard, N. M. Bass, and H. Carlier . 1995 . Expression of fatty acid binding protein in the liver during pregnancy and lactation in the rat. Biochim. Biophys. Acta . 1258 : 153 - 158 .
31. Singer, S. S., K. Henkels, A. Deucher, M. Barker, J. Singer, and D. V. Trulzsch . 1996 . Growth hormone and aging change rat liver fatty acid binding protein levels. J. Am. Coll. Nutr. 15 : 169 - 174 .
32. Ockner, R. K., N. Lysenko, J. A. Manning, S. E. Monroe, and D. A. Burnett . 1980 . Sex steroid modulation of fatty acid utilization and fatty acid binding protein concentration in rat liver. J. Clin. Invest. 65 : 1013 - 1023 .
33. Bass, N. M., J. A. Manning, R. K. Ockner, J. I. Gordon, S. Seetharam, and D. H. Alpers . 1985 . Regulation of the biosynthesis of two distinct fatty acid-binding proteins in rat liver and intestine. J. Biol. Chem. 260 : 1432 - 1436.
34. Stein, L. B., S. Mishkin, G. Fleischner, Z. Gatmaitan, and I. M. Arias . 1976 . Effect of fasting on hepatic ligandin, Z protein, and organic anion transfer from plasma in rats. Am. J. Physiol. 231 : 1371 - 1376 .
35. Brandes, R., and R. Arad . 1983 . Liver cytosolic fatty acid-binding proteins. Effect of diabetes and starvation. Biochim. Biophys. Acta . 750 : 334 - 339 .
36. Paulussen, R. J. A., G. P. M. Jansen, and J. H. Veerkamp . 1986 . Fatty acid-binding capacity of cytosolic proteins of various rat tissues: Effect of postnatal development, starvation, sex, clofi brate feeding and light cycle. Biochim. Biophys. Acta . 877 : 342 - 349 .
37. Haq, R. U., and E. Shrago . 1985 . Dietary and nutritional aspects of fatty acid binding proteins. Chem. Phys. Lipids . 38 : 131 - 135 .
38. Pignon, J. P., N. C. Bailey, E. Baraona, and C. S. Lieber . 1987 . Fatty acid-binding protein: A major contributor to the ethanolinduced increase in liver cytosolic proteins in the rat. Hepatology . 7 : 865 - 871 .
39. Shevchuk, O., E. Baraona, X-L. Ma, J-P. Pignon, and C. S. Lieber . 1991 . Gender differences in the response of hepatic fatty acids and cytosolic fatty acid-binding capacity to alcohol consumption in rats. Proc. Soc. Exp. Biol. Med. 198 : 584 - 590 .
40. Janevski, M., K. N. Antonas, M. J. Sullivan-Gunn, M. A. McGlynn, and P. A. Lewandowski . 2011 . The effect of cocoa supplementation on hepatic steatosis, reactive oxygen species and LFABP in a rat model of NASH. Comp. Hepatol. 10 : 10 .
41. Foucaud, L., I. Niot, T. Kanda, and P. Besnard . 1998 . Indirect dexamethasone down-regulation of the liver fatty acid-binding protein expression in rat liver. Biochim. Biophys. Acta . 1391 : 204 - 212 .
42. Atshaves, B. P., G. G. Martin, H. A. Hostetler, A. L. McIntosh, A. B. Kier, and F. Schroeder . 2010 . Liver fatty acid-binding protein and obesity. J. Nutr. Biochem. 21 : 1015 - 1032 .
43. Haunerland, N. H., and F. Spener . 2004 . Fatty acid-binding proteins- insights from genetic manipulations. Prog. Lipid Res. 43 : 328 - 349.
44. Storch, J., and B. Corsico . 2008 . The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu. Rev. Nutr. 28 : 73 - 95 .
45. Furuhashi, M., and G. S. Hotamisligil . 2008 . Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov. 7 : 489 - 503 .
46. Raza, H., J. R. Pongubala, and S. Sorof . 1989 . Specifi c high affi nity binding of lipoxygenase metabolites of arachidonic acid by liver fatty acid binding protein. Biochem. Biophys. Res. Commun. 161 : 448 - 455 .
47. Atshaves, B. P., S. M. Storey, A. Petrescu, C. C. Greenberg, O. I. Lyuksyutova, R. Smith 3rd, and F. Schroeder . 2002 . Expression of fatty acid binding proteins inhibits lipid accumulation and alters toxicity in L cell fi broblasts. Am. J. Physiol. Cell Physiol. 283 : C688 - C703 .
48. Larsen, R., Z. Gouveia, M. P. Soares, and R. Gozzelino . 2012 . Heme cytotoxicity and the pathogenesis of immune-mediated infl ammatory diseases. Front. Pharmacol. 3 : 77 .
49. Ek-Von Mentzer, B. A., F. Zhang, and J. A. Hamilton . 2001 . Binding of 13-HODE and 15-HETE to phospholipid bilayers, albumin, and intracellular fatty acid binding proteins. J. Biol. Chem. 276 : 15575 - 15580 .
50. Ek, B. A., D. P. Cistola, J. A. Hamilton, T. L. Kaduce, and A. A. Spector . 1997 . Fatty acid binding proteins reduce 15-lipoxygenase- induced oxygenation of linoleic acid and arachidonic acid. Biochim. Biophys. Acta . 1346 : 75 - 85 .
51. Catala, A., A. Cerruti, and C. Arcemis . 1995 . Inhibition of microsomal chemiluminescence by cytosolic fractions containing fatty acid binding protein. Arch. Physiol. Biochem. 103 : 39 - 43 .
52. Samanta, A., D. K. Das, R. Jones, A. George, and M. R. Prasad . 1989 . Free radical scavenging by myocardial fatty acid binding protein. Free Radic. Res. Commun. 7 : 73 - 82 .
53. Day, C. P., and O. F. James . 1998 . Hepatic steatosis: innocent bystander or guilty party? Hepatology . 27 : 1463 - 1466 .
54. Csonka, C., T. Pataki, P. Kovacs, S. L. Muller, M. L. Schroeter, A. Tosaki, and I. E. Blasig . 2000 . Effects of oxidative stress on the expression of antioxidative defense enzymes in spontaneously hypertensive rat hearts. Free Radic. Biol. Med. 29 : 612 - 619 .
55. Thomas, J. A., B. Poland, and R. Honzatko . 1995 . Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation. Arch. Biochem. Biophys. 319 : 1 - 9 .
56. Odani, S., Y. Namba, A. Ishii, T. Ono, and H. Fujii . 2000 . Disulfi de bonds in rat cutaneous fatty acid-binding protein. J. Biochem. 128 : 355 - 361 .
57. Levine, R. L., B. S. Berlett, J. Moskovitz, L. Mosoni, and E. R. Stadtman . 1999 . Methionine residues may protect proteins from critical oxidative damage. Mech. Ageing Dev. 107 : 323 - 332 .
58. Moskovitz, J., B. S. Berlett, J. M. Poston, and E. R. Stadtman . 1999 . Methionine sulfoxide reductase in antioxidant defense. Methods Enzymol. 300 : 239 - 244 .
59. Moskovitz, J., N. A. Jenkins, D. J. Gilbert, N. G. Copeland, F. Jursky, H. Weissbach, and N. Brot . 1996 . Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues. Proc. Natl. Acad. Sci. USA . 93 : 3205 - 3208 .
60. Stadtman, E. R. 2004 . Cyclic oxidation and reduction of methionine residues of proteins in antioxidant defense and cellular regulation. Arch. Biochem. Biophys. 423 : 2 - 5 .
61. Moskovitz, J., S. Bar-Noy, W. M. Williams, J. Requena, B. S. Berlett, and E. R. Stadtman . 2001 . Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals. Proc. Natl. Acad. Sci. USA . 98 : 12920 - 12925 .
62. Stadtman, E. R., J. Moskovitz, B. S. Berlett, and R. L. Levine . 2002 . Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol. Cell. Biochem. 234-235 : 3 - 9 .
63. Yan, J., Y. Gong, Y. M. She, G. Wang, M. S. Roberts, and F. J. Burczynski . 2009 . Molecular mechanism of recombinant liver fatty acid binding protein's antioxidant activity. J. Lipid Res. 50 : 2445 - 2454 .
64. Sato, T., K. Baba, Y. Takahashi, T. Uchiumi, and S. Odani . 1996 . Rat liver fatty acid-binding protein: identifi cation of a molecular species having a mixed disulfi de with cysteine at cysteine-69 and enhanced protease susceptibility. J. Biochem. 120 : 908 - 914 .
65. Palacios, A., V. A. Piergiacomi, and A. Catala . 1999 . Inhibition of lipid peroxidation of microsomes and mitochondria by cytosolic proteins from rat liver: Effect of vitamin A. Int. J. Vitam. Nutr. Res. 69 : 61 - 63 .
66. Wang, G., Y. Gong, J. Anderson, D. Sun, G. Minuk, M. S. Roberts, and F. J. Burczynski . 2005 . Antioxidative function of L-FABP in L-FABP stable transfected Chang liver cells. Hepatology . 42 : 871 - 879 .
67. Yan, J., Y. Gong, G. Wang, and F. J. Burczynski . 2010 . Regulation of liver fatty acid binding protein expression by clofi brate in hepatoma cells. Biochem. Cell Biol. 88 : 957 - 967 .
68. Wang, G., H. Shen, G. Rajaraman, M. S. Roberts, Y. Gong, P. Jiang, and F. Burczynski . 2007 . Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats. Eur. J. Pharmacol. 560 : 61 - 68 .
69. Smathers, R. L., J. J. Galligan, C. T. Shearn, K. S. Fritz, K. Mercer, M. Ronis, D. J. Orlicky, N. O. Davidson, and D. R. Petersen . 2013 . Susceptibility of L-FABP-/- mice to oxidative stress in early-stage alcoholic liver. J. Lipid Res. 54 : 1335 - 1345 .
70. Yamauchi, S., N. Kiyosawa, Y. Ando, K. Watanabe, N. Niino, K. Ito, T. Yamoto, S. Manabe, and A. Sanbuissho . 2011 . Hepatic transcriptome and proteome responses against diethyl maleate-induced glutathione depletion in the rat. Arch. Toxicol. 85 : 1045 - 1056 .
71. Fong, D. G., V. Nehra, K. D. Lindor, and A. L. Buchman . 2000 . Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology . 32 : 3 - 10 .
72. Farrell, G. C. 1995 . Drug-Induced Liver Diseases. Churchill Livingstone, New York.
73. Lieber, C. S., and C. S. Abittan . 1999 . Pharmacology and metabolism of alcohol, including its metabolic effects and interactions with other drugs. Clin. Dermatol. 17 : 365 - 379 .
74. Albano, E., L. Goria-Gatti, P. Clot, A. Jannone, and A. Tomasi . 1993 . Possible role of free radical intermediates in hepatotoxicity of hydrazine derivatives. Toxicol. Ind. Health . 9 : 529 - 538 .
75. Gong, Y., G. Wang, Y. Gong, J. Yan, Y. Chen, and F. J. Burczynski . 2014 . Hepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity. BMC Gastroenterol. 14 : 44 .
76. Maatman, R. G., T. H. Van Kuppevelt, and J. H. Veerkamp . 1991 . Two types of fatty acid-binding protein in human kidney. Isolation, characterization and localization. Biochem. J. 273 : 759 - 766 .
77. Kanaguchi, Y., Y. Suzuki, K. Osaki, T. Sugaya, S. Horikoshi, and Y. Tomino . 2011 . Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis. Nephrol. Dial. Transplant. 26 : 3465 - 3473 .
78. Ichikawa, D., A. Kamijo-Ikemori, T. Sugaya, T. Yasuda, S. Hoshino, J. Igarashi-Migitaka, K. Hirata, and K. Kimura . 2012 . Renal livertype fatty acid binding protein attenuates angiotensin II-induced renal injury. Hypertension . 60 : 973 - 980 .
79. Kamijo-Ikemori, A., T. Sugaya, A. Obama, J. Hiroi, H. Miura, M. Watanabe, T. Kumai, R. Ohtani-Kaneko, K. Hirata, and K. Kimura . 2006 . Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am. J. Pathol. 169 : 1107 - 1117 .
80. Vincent, S. H., and U. Muller-Eberhard . 1985 . A protein of the Z class of liver cytosolic proteins in the rat that preferentially binds heme. J. Biol. Chem. 260 : 14521 - 14528.
81. Epstein, L. F., N. M. Bass, S. Iwahara, D. C. Wilton, and U. Muller Eberhard . 1994 . Immunological identity of rat liver cytosolic heme-binding protein with purifi ed and recombinant liver fatty acid binding protein by western blots of two-dimensional gels. Biochem. Biophys. Res. Commun. 204 : 163 - 168 .
82. Fanali, G., A. Bocedi, P. Ascenzi, and M. Fasano . 2007 . Modulation of heme and myristate binding to human serum albumin by anti- HIV drugs. An optical and NMR spectroscopic study. FEBS J. 274 : 4491 - 4502.
83. Stewart, J. M., G. W. Slysz, M. A. Pritting, and U. Muller-Eberhard . 1996 . Ferriheme and ferroheme are isosteric inhibitors of fatty acid binding to rat liver fatty acid binding protein. Biochem. Cell Biol. 74 : 249 - 255 .
84. Neuwirt, J., P. Ponka, and J. Borova . 1972 . Evidence for the presence of free and protein-bound nonhemoglobin heme in rabbit reticulocytes. Biochim. Biophys. Acta . 264 : 235 - 244 .
85. Liem, H. H., J. A. Grasso, S. H. Vincent, and U. Muller-Eberhard . 1990 . Protein-mediated effl ux of heme from isolated rat liver mitochondria. Biochem. Biophys. Res. Commun. 167 : 528 - 534 .
86. Vítek, L., and H. A. Schwertner . 2007 . The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv. Clin. Chem. 43 : 1 - 57 .
87. Qian, Y., and J. G. Fan . 2005 . Obesity, fatty liver and liver cancer. . Hepatobiliary Pancreat. Dis. Int. 4 : 173 - 177 .
88. Guilmeau, S., I. Niot, J. P. Laigneau, H. Devaud, V. Petit, N. Brousse, R. Bouvier, L. Ferkdadji, C. Besmond, L. P. Aggerbeck, et al . 2007 . Decreased expression of Intestinal I- And L-FABP levels in rare human genetic lipid malabsorption syndromes. Histochem. Cell Biol. 128 : 115 - 123 .
89. Charlton, M., K. Viker, A. Krishnan, S. Sanderson, B. Veldt, A. J. Kaalsbeek, M. Kendrick, G. Thompson, F. Que, J. Swain, et al . 2009 . Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology . 49 : 1375 - 1384 .
90. Guzm á n, C., M. Benet, S. Pisonero-Vaquero, M. Moya, M. V. Garcia-Mediavilla, M. L. Martínez-Chantar, J. Gonz á lez-Gallego, J. V. Castell, S. S á nchez-Campos, and R. Jover . 2013 . The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPAR -; and repressed by C/EBP - : Implications in FABP1 down-regulation in nonalcoholic fatty liver disease. Biochim. Biophys. Acta . 1831 : 803 - 818 .
91. Rinella, M. E., M. S. Elias, R. R. Smolak, T. Fu, J. Borensztajn, and R. M. Green . 2008 . Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-defi cient diet. J. Lipid Res. 49 : 1068 - 1076 .
92. Hung, D. Y., G. A. Siebert, P. Chang, F. J. Burczynski, and M. S. Roberts . 2005 . Reduced hepatic extraction of palmitate in steatosis correlated to lower level of liver fatty acid binding protein. Am. J. Physiol. Gastrointest. Liver Physiol. 288 : G93 - G100 .
93. Wolfrum, C., P. Ellinghaus, M. Fobker, U. Seedorf, G. Assmann, T. Borchers, and F. Spener . 1999 . Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein. J. Lipid Res. 40 : 708 - 714 .
94. Devarshi, P. P., N. M. Jangale, A. E. Ghule, S. L. Bodhankar, and A. M. Harsulkar . 2013 . Benefi cial effects of fl axseed oil and fi sh oil diet are through modulation of different hepatic genes involved in lipid metabolism in streptozotocin-nicotinamide induced diabetic rats. Genes Nutr. 8 : 329 - 342 .
95. Petrescu, A. D., H. Huang, G. G. Martin, A. L. McIntosh, S. M. Storey, D. Landrock, A. B. Kier, and F. Schroeder . 2013 . Impact of L-FABP and glucose on polyunsaturated fatty acid induction of PPARalpha-regulated beta-oxidative enzymes. Am. J. Physiol. Gastrointest. Liver Physiol. 304 : G241 - G256 .
96. Nanji, A. A., A. J. Dannenberg, K. Jokelainen, and N. M. Bass . 2004 . Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-alpha (PPARalpha)-regulated genes and is ameliorated by PPARalpha activation. J. Pharmacol. Exp. Ther. 310 : 417 - 424 .
97. Brouillette, C., Y. Bosse, L. Perusse, D. Gaudet, and M. C. Vohl . 2004 . Effect of liver fatty acid binding protein (FABP) T94A missense mutation on plasma lipoprotein responsiveness to treatment with fenofi brate. J. Hum. Genet. 49 : 424 - 432 .
98. Peng, X. E., Y. L. Wu, Q. Q. Lu, Z. J. Hu, and X. Lin . 2012 . Two genetic variants in FABP1 and susceptibility to non-alcohol fatty liver disease in a Chinese population. Gene . 500 : 54 - 58 .
99. McIntosh, A. L., H. Huang, S. M. Storey, K. K. Landrock, D. Landrock, A. D. Petrescu, S. Gupta, B. P. Atshaves, A. B. Kier, and F. Schroeder . 2014 . Human FABP1 T94A variant impacts fatty acid metabolism and PPAR-alpha activation in cultured human female hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 307 : G164 - G176 .
100. Fisher, E., C. Weikert, M. Klapper, I. Lindner, M. Mohlig, J. Spranger, H. Boeing, J. Schrezenmeir, and F. Doring . 2007 . L-FABP T94A is associated with fasting triglycerides and LDLcholesterol in women. Mol. Genet. Metab. 91 : 278 - 284 .
101. Martin, G. G., A. L. McIntosh, H. Huang, S. Gupta, B. P. Atshaves, K. K. Landrock, D. Landrock, A. B. Kier, and F. Schroeder . 2013 . The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fi brates. Biochemistry . 52 : 9347 - 9357 .
102. Huang, H., A. L. McIntosh, G. G. Martin, K. K. Landrock, D. Landrock, S. Gupta, B. P. Atshaves, A. B. Kier, and F. Schroeder . 2014 . Structural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variant. FEBS J. 281 : 2266 - 2283 .
103. Mansego, M. L., F. Martinez, M. T. Martinez-Larrad, C. Zabena, G. Rojo, S. Morcillo, F. Soriguer, J. C. Martin-Escudero, M. Serrano-Rios, J. Redon, et al . 2012 . C ommon variants of the liver fatty acid binding protein gene influencethe risk of type 2 diabetes and insulin resistance in Spanish population. PLoS One . 7 : E31853 .
104. Martin, G. G., H. Danneberg, L. S. Kumar, B. P. Atshaves, E. Erol, M. Bader, F. Schroeder, and B. Binas . 2003 . Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene. J. Biol. Chem. 278 : 21429 - 21438 .
105. Newberry, E. P., Y. Xie, S. Kennedy, X. Han, K. K. Buhman, J. Luo, R. W. Gross, and N. O. Davidson . 2003 . Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene. J. Biol. Chem. 278 : 51664 - 51672 .
106. Martin, G. G., B. P. Atshaves, H. Huang, A. L. McIntosh, B. J. Williams, P. J. Pai, D. H. Russell, A. B. Kier, and F. Schroeder . 2009 . Hepatic phenotype of liver fatty acid binding protein gene-ablated mice. Am. J. Physiol. Gastrointest. Liver Physiol. 297 : G1053 - G1065 .
107. Erol, E., L. S. Kumar, G. W. Cline, G. I. Shulman, D. P. Kelly, and B. Binas . 2004 . Liver fatty acid binding protein is required for high rates of hepatic fatty acid oxidation but not for the action of PPARalpha in fasting mice. FASEB J. 18 : 347 - 349 .
108. Storey, S. M., A. L. McIntosh, H. Huang, G. G. Martin, K. K. Landrock, D. Landrock, H. R. Payne, A. B. Kier, and F. Schroeder . 2012 . Loss of intracellular lipid binding proteins differentially impacts saturated fatty acid uptake and nuclear targeting in mouse hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 303 : G837 - G850 .
109. Gao, N., X. Qu, J. Yan, Q. Huang, H. Y. Yuan, and D. S. Ouyang . 2010 . L-FABP T94A decreased fatty acid uptake and altered hepatic triglyceride and cholesterol accumulation in Chang liver cells stably transfected with L-FABP. Mol. Cell. Biochem. 345 : 207 - 214 .
110. Martin, G. G., B. P. Atshaves, A. L. McIntosh, H. R. Payne, J. T. Mackie, A. B. Kier, and F. Schroeder . 2009 . Liver fatty acid binding protein gene ablation enhances age-dependent weight gain in male mice. Mol. Cell. Biochem. 324 : 101 - 115 .
111. Atshaves, B. P., A. L. McIntosh, S. M. Storey, K. K. Landrock, A. B. Kier, and F. Schroeder . 2010 . High dietary fat exacerbates weight gain and obesity in female liver fatty acid binding protein geneablated mice. Lipids . 45 : 97 - 110 .
112. McIntosh, A. L., B. P. Atshaves, D. Landrock, K. K. Landrock, G. G. Martin, S. M. Storey, A. B. Kier, and F. Schroeder . 2013 . Liver fatty acid binding protein gene-ablation exacerbates weight gain in high-fat fed female mice. Lipids . 48 : 435 - 448 .
113. Martin, G. G., B. P. Atshaves, A. L. McIntosh, J. T. Mackie, A. B. Kier, and F. Schroeder . 2006 . Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol- fed female mice. Am. J. Physiol. Gastrointest. Liver Physiol. 290 : G36 - G48 .
114. Martin, G. G., B. P. Atshaves, A. L. McIntosh, J. T. Mackie, A. B. Kier, and F. Schroeder . 2005 . Liver fatty-acid-binding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice. Biochem. J. 391 : 549 - 560 .
115. Newberry, E. P., Y. Xie, S. M. Kennedy, J. Luo, and N. O. Davidson . 2006 . Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology . 44 : 1191 - 1205.
116. Newberry, E. P., S. M. Kennedy, Y. Xie, J. Luo, R. M. Crooke, M. J. Graham, J. Fu, D. Piomelli, and N. O. Davidson . 2012 . Decreased body weight and hepatic steatosis with altered fatty acid ethanolamide metabolism in aged L-Fabp -/- mice. J. Lipid Res. 53 : 744 - 754 .
117. Chen, A., Y. Tang, V. Davis, F. F. Hsu, S. M. Kennedy, H. Song, J. Turk, E. M. Brunt, E. P. Newberry, and N. O. Davidson . 2013 . Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease. Hepatology . 57 : 2202 - 2212 .
118. Newberry, E. P., S. M. Kennedy, Y. Xie, B. T. Sternard, J. Luo, and N. O. Davidson . 2008 . Diet-induced obesity and hepatic steatosis in L-Fabp/mice is abrogated with SF, but not PUFA, feeding and attenuated after cholesterol supplementation. Am. J. Physiol. Gastrointest. Liver Physiol. 294 : G307 - G314 .
119. Newberry, E. P., S. M. Kennedy, Y. Xie, J. Luo, and N. O. Davidson . 2009 . Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout mice. Mol. Cell. Biochem. 326 : 79 - 86 .
120. Newberry, E. P., and N. O. Davidson . 2009 . Liver fatty acid binding protein (L-FABP) as a target for the prevention of high fat diet induced obesity and hepatic steatosis. Immunol. Endocr. Metab. Agents Med. Chem. 9 : 30 - 37 .
121. Huang, W. Y., J. Aramburu, P. S. Douglas, and S. Izumo . 2000 . Transgenic expression of green fl uorescence protein can cause dilated cardiomyopathy. Nat. Med. 6 : 482 - 483 .
122. Agbulut, O., C. Coirault, N. Niederlander, A. Huet, P. Vicart, A. Hagege, M. Puceat, and P. Menasche . 2006 . GFP expression in muscle cells impairs actin-myosin interactions: implications for cell therapy. Nat. Methods . 3 : 331 .
123. Stripecke, R., M. Carmen Villacres, D. Skelton, N. Satake, S. Halene, and D. Kohn . 1999 . Immune response to green fl uorescent protein: implications for gene therapy. Gene Ther. 6 : 1305 - 1312 .
124. Li, H., H. Wei, Y. Wang, H. Tang, and Y. Wang . 2013 . Enhanced green fl uorescent protein transgenic expression in vivo is not biologically inert. J. Proteome Res. 12 : 3801 - 3808 .
125. Huang, H., O. Starodub, A. McIntosh, A. B. Kier, and F. Schroeder . 2002 . Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fl uorescence imaging in living cells. J. Biol. Chem. 277 : 29139 - 29151 .
126. Williams, M. A., K. T. Tamai, I. Hincenbergs, and D. J. McIntosh . 1972 . Hydrogenated coconut oil and tissue fatty acids in EFAdepleted and EFA-supplemented rats. J. Nutr. 102 : 847 - 855 .
127. Georgiadi, A., and S. Kersten . 2012 . Mechanisms of gene regulation by fatty acids. Adv. Nutr. 3 : 127 - 134 .
128. McArthur, M. J., B. P. Atshaves, A. Frolov, W. D. Foxworth, A. B. Kier, and F. Schroeder . 1999 . Cellular uptake and intracellular traffi cking of long chain fatty acids. J. Lipid Res. 40 : 1371 - 1383 .
129. Turnbaugh, P. J., F. Backhed, L. Fulton, and J. I. Gordon . 2008 . Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe . 3 : 213 - 223 .
130. Atshaves, B. P., S. M. Storey, H. Huang, and F. Schroeder . 2004 . Liver fatty acid binding protein expression enhances branchedchain fatty acid metabolism. Mol. Cell. Biochem. 259 : 115 - 129 .
131. Luxon, B. A., and M. T. Milliano . 1997 . Cytoplasmic codiffusion of fatty acids is not specifi c for fatty acid binding protein. Am. J. Physiol. 273 : C859 - C867 .
132. Memon, R. A., N. M. Bass, A. H. Moser, J. Fuller, R. Appel, C. Grunfeld, and K. R. Feingold . 1999 . Down-regulation of liver and heart specifi c fatty acid binding proteins by endotoxin and cytokines in vivo. Biochim. Biophys. Acta . 1440 : 118 - 126.
133. Mikolajczak, S. A., V. Jacobs-Lorena, D. C. MacKellar, N. Camargo, and S. H. Kappe . 2007 . L-FABP is a critical host factor for successful malaria liver stage development. Int. J. Parasitol. 37 : 483 - 489 .